biomarker validation
Genialis Inks Data Partnerships with Sidra Medicine, Sapien Biosciences
The firm said the data would help it validate RNA biomarkers on diverse patient populations to better predict responses to emerging drug classes.
One independent researcher called the study "a valuable guide for experimental validation of circRNAs" in cancer and neurodegenerative disease research.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
Function Oncology Launches With $28M, Seeks to Transform Precision Cancer Therapy With CRISPR
Premium
The firm unveiled early validation data for its CRISPR-based functional genomics platform, which it hopes to commercialize as another tool doctors can use to individualize cancer care.
Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
Immune-related gene expression signatures tracked more closely with treatment response and outcomes than tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer.